Trial intelligence / Profile preview

High-Dose Hepatitis B Vaccine in Non-Responders

NCT01203319Phase 3Completed

Sponsor
Jiangsu Provincial Center for Disease Control and Prevention
Start
Nov 2006
Primary completion
Dec 2010
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 3 trial of recombinant hepatitis B vaccine Bio Farma in hepatitis B (HBV), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Nov 2006; status: completed.

02

Drugs

recombinant hepatitis B vaccine Bio Farma
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT01203319.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01203319.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call